$6.00
-0.25 (-3.92%)
Open$6.53
Previous Close$6.25
Day High$6.53
Day Low$6.00
52W High$18.40
52W Low$4.35
Volume—
Avg Volume10.1K
Market Cap58.80M
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 13.14M | 13.93M | 11.00M |
| Net Income | -2,417,675 | -2,785,079 | -2,350,186 |
| Profit Margin | -18.4% | -20.0% | -21.4% |
| EBITDA | -3,490,436 | -4,206,535 | -3,083,781 |
| Free Cash Flow | -1,263,655 | -1,934,401 | -1,577,892 |
| Rev Growth | -4.0% | +11.1% | -5.6% |
| Debt/Equity | 0.43 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |